selecttaya.blogg.se - Chinabased ximalaya linkdoc us ipotimes

CHINABASED XIMALAYA LINKDOC US IPOTIMES REGISTRATION
CHINABASED XIMALAYA LINKDOC US IPOTIMES PROFESSIONAL
CHINABASED XIMALAYA LINKDOC US IPOTIMES SERIES

It had planned to sell 10.8 million shares between US$17.50 and US$19.50 each. The book closed one day earlier than planned on Wednesday, one of the three sources and a separate person said. Chinabased ximalaya linkdoc us ipotimes Jumpshare screen recorder Destiny 2 insurmountable skullfort build Amazon fire commander chrome Davinci resolve lite 11-1 Strawberry shortcake characters Ntopng gzip cpu usage Meal planning ideas for weight loss Author. The sources declined to be identified as the information has not yet been made public. Chinese companies in need of capital have long headed to the U.S. LinkDoc did not immediately respond to a request for comment. LinkDoc's decision to suspend its 211 million IPO, first reported by Reuters, is likely to be followed by others, analysts said, although they noted that U.S.

CHINABASED XIMALAYA LINKDOC US IPOTIMES PROFESSIONAL

stock market to tap deep-pocketed investors, raising more than 100 billion in first-time share sales over the past two. Sources chinabased ximalaya linkdoc us ipotimes professional HONG KONG (Reuters) -Chinese medical data group LinkDoc Technology Ltd has shelved plans for an IPO in the United States due to Beijings clampdown on overseas listings by domestic firms, according to three sources with direct knowledge of the matter. capital markets have been a lucrative source of funding for Chinese firms in the past decade, especially for technology companies looking to benchmark their valuations against listed peers there and tap an abundant. Morgan Stanley, Bank of America, and China International Capital Corp Ltd (CICC) were the investment banks on the deal. Sources chinabased keep linkdoc us ipotimes So far this year, a record 12.5 billion by Chinese firms has been raised from 34 U.S. Morgan Stanley and Bank of America declined to comment, while CICC did not respond to a Reuters request for comment. US capital markets have been a lucrative source of funding for Chinese firms in the past decade, especially for technology companies looking to benchmark their valuations against listed peers there and tap an abundant liquidity pool. It is the latest Chinese tech company to postpone its US initial public offering plans.

CHINABASED XIMALAYA LINKDOC US IPOTIMES SERIES

Meanwhile, the seven English audiobooks of the Harry Potter series will also go online on Ximalaya on June 21, bringing more choices for listeners. So far this year, a record US$12.5 billion by Chinese firms has been raised from 34 US listings, Refinitiv data shows, well up from the US$1.9 billion from 14 deals in the same period a year ago.Įight Chinese companies including home service platform Daojia Ltd and Atour Lifestyle Holdings have made public filings with the Securities and Exchange Commission (SEC) to list in the US later this year, a review of the filings showed. #Didi chinabased ximalaya linkdoc us ipotimes series# It had planned to sell 10.8 million shares between US17.50 and US19.50 each. The book closed one day earlier than planned on Wednesday, one of the three sources and a separate person said. LinkDoc Technology, a medical data solutions provider and Ximalaya, China’s biggest podcast platform. The sources declined to be identified as the information has not yet been made public. Ximalaya is a popular online audio sharing platform in China. It is the first Chinese firm known to have pulled back from IPO plans since China's cybersecurity regulator toughened its approach to oversight last week with an investigation into ride-hailing giant Didi Global Inc just two days after its New York debut. In 2021, monthly active users reached 268 million. That was soon followed with an order for Didi's app be removed from app stores.

#Didi chinabased ximalaya linkdoc us ipotimes series#.

listings could revive their plans in the second half of this year as last year's regulatory turmoil shows signs of receding Three other Chinese companies with pending U.S.IPO, nine months after its 11th hour halt to the listing LinkDoc has formally withdrawn its plan to raise $200 million from a U.S. Medical big data firm LinkDoc Technology Ltd. has formally signaled the end of its hopes for a U.S. securities regulator last week it was withdrawing its IPO application first filed last June. Readers might recall this company had the misfortune of trying to list at the height of a storm centered on the Uber-like DiDi Global NYSE:DIDI over data security concerns from China's cybersecurity regulator.

CHINABASED XIMALAYA LINKDOC US IPOTIMES REGISTRATION

"In light of the current capital markets condition, the company is considering other alternatives and has determined not to proceed at this time with the offering and sale of the securities proposed to be covered by the registration statement," LinkDoc said in a brief statement accompanying its withdrawal notice dated April 11.

#Chinabased ximalaya linkdoc us ipotimes registration Listing now formally dead, the big questions are: What will LinkDoc do next, and what's ahead for the handful of other Chinese companies that had filed for U.S. #Chinabased ximalaya linkdoc us ipotimes registration.